- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02895477
Quest Sound Recover (SR2) vs. Venture SR2
January 27, 2017 updated by: Sonova AG
Goal of this study is to determine the benefit of an improved feature on a new hearing aid platform.
To investigate the improvements of this feature is compared on a new and older hearing aid platform. The obtained results will be used for future improvement for this feature. This feature should improve the speech understanding and speech recognition of the hearing aid user.
Study Overview
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zürich
-
Stäfa, Zürich, Switzerland, 8712
- Sonova AG
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- Ability to fill in a question conscientious
- Healthy outer ear (w/o previous surgical procedures)
- Sensorineural symmetric hearing loss (HL)
- N4 to N7 (degree of HL)
Exclusion Criteria:
- Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product,
- Limited mobility and not in the position to attend weekly appointments
- Limited ability to describe listening impressions/experiences and the use of the hearing aid
- Inability to produce a reliable hearing test result when pure tone audiometry is attempted by the audiologist
- Massively limited dexterity
- Known Psychological problems
- Central hearing problems
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Hearing aid
|
|
Experimental: Test group
Hearing aid
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional gain
Time Frame: after 2 weeks
|
Functional gain is to measure the aided threshold (in dB hearing level [HL]) in free field via loudspeaker.
|
after 2 weeks
|
Phoneme Perception Test
Time Frame: after 2
|
Change of Detection thresholds after 4 weeks hearing instrument wearing time
|
after 2
|
Functional gain
Time Frame: after 8 weeks
|
Functional gain is to measure the aided threshold (in dB hearing level [HL]) in free field via loudspeaker.
|
after 8 weeks
|
Phoneme Perception Test
Time Frame: after 8 weeks
|
Change of detection thresholds after 4 weeks hearing instrument wearing time
|
after 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
sound quality ratings
Time Frame: after 6 and 12 weeks
|
after 6 and 12 weeks
|
questionnaires
Time Frame: after 2, 6, 8 and 12 weeks
|
after 2, 6, 8 and 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
January 20, 2017
Study Registration Dates
First Submitted
August 29, 2016
First Submitted That Met QC Criteria
September 5, 2016
First Posted (Estimate)
September 9, 2016
Study Record Updates
Last Update Posted (Estimate)
January 30, 2017
Last Update Submitted That Met QC Criteria
January 27, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Sonova2016_10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Otologic Pharmaceutics, Inc.CompletedHearing Loss | Sensorineural Hearing Loss | Noise-Induced Hearing LossUnited States
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
Clinical Trials on hearing aid
-
Northwestern UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
Sonova AGCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralCanada
-
Bernafon AGCompletedHearing LossSwitzerland
-
Sonova AGCompleted
-
Sonova AGWestern UniversityRecruiting
-
Sonova AGCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralCanada
-
Sonova AGCompleted
-
Sonova AGCompletedHearing Loss | Normal HearingSwitzerland